Survival analysis indicated that RCC patients characterized by HIF1α-high/HIF2α-low marker profile had the worst outcome while the opposite was found for patients belonging to the HIF1α-low/HIF2α-high group (Figure 4). The gene discussed is EPAS1; the disease is renal cell adenocarcinoma.